Young adults who use methamphetamine may be more vulnerable to age-related brain degeneration when they grow older, new animal research suggests.
“The emergence of behavioral deficits in animals months after methamphetamine discontinuation may be relevant to human methamphetamine abusers,” says Nora Volkow, MD, director of the National Institute for Drug Abuse. “It suggests that even though their current use may not result in deficits, as they age these deficits will become manifest.” Volkow did not participate in the study.
The new work examines the idea that methamphetamine puts young users at risk of developing deficits later in life that are symptomatic of Parkinson’s disease in individuals with depletion of glial derived neurotrophic factor (GDNF), a protein that protects and repairs dopamine in areas of the brain related to movement control. Loss of nerve cells that produce dopamine is a major factor in the disease.
In their work, published August 15 in The Journal of Neuroscience, Jacqueline McGinty, PhD, at the Medical University of South Carolina, and her colleagues examined the role of GDNF in mice. At 2.5 months of age, the equivalent of adolescence in humans, mice with a partial GDNF gene deletion were compared to mice without the gene deletion; both were given either methamphetamine or saline injections four times over an eight-hour period. McGinty’s team discovered that the effects of this methamphetamine binge were exacerbated in the mice with the GDNF deletion. In addition, at 12 months, the GDNF-depleted mice moved significantly less than genetically normal mice treated with methamphetamine.
“Methamphetamine intoxication in any young adult may have deleterious consequences later in life, although they may not be apparent until many decades after the exposure,” says McGinty. “These studies speak directly to the possibility of long-term public health consequences resulting from the current epidemic of methamphetamine abuse among young adults.”
Future studies might involve identifying the reasons for increased vulnerability to methamphetamine in GDNF-depleted mice in order to help minimize the harm methamphetamine causes to the brain..
Source: Society for Neuroscience
Related stories:
Study finds a new mechanism for how methamphetamine affects the developing fetal brain
(PhysOrg.com) -- University of Toronto researchers have discovered a new mechanism in mice that shows how the exposure to the illicit drug methamphetamine (METH) during pregnancy can adversely affect the developing fetal brain.
Meth addiction mechanism discovered
Researchers have identified, for the first time, long-term changes in the brain circuitry of methamphetamine-addicted mice that can explain why the craving of addiction is so stubborn and long-lived. The research could lead to more effective treatments for addiction to methamphetamine and related drugs.
Stress triggers relapse in meth abuse, study finds
Oregon Health & Science University research showing stress triggers a relapse of methamphetamine abuse in mice could be a step toward developing a drug to curb this frustrating obstacle to recovery.
Methamphetamine abuse linked to underage sex, smoking and drinking
Teens who have never done drugs, but engage in other risky behaviours such as drinking, smoking and being sexually active, are more likely to use crystal meth, medical researchers at the University of Alberta have concluded. Among teens already doing other drugs, those with unstable family environments are most likely to do crystal meth, found the research team led by Dr. Terry Klassen, a professor in the Department of Pediatrics in the Faculty of Medicine & Dentistry.
Hope for treating relapse to methamphetamine abuse
A new study at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory suggests that vigabatrin (a.k.a. gamma vinyl-GABA, or GVG) blocks drug-seeking behavior in animals previously trained to associate methamphetamine with a particular environment. Specifically, animals pre-treated with vigabatrin lost interest in spending time in a location where they had previously been given methamphetamine. The results will appear in the February 2009 issue of
Synapse, now available online.
Methamphetamine abuse linked to underage sex, smoking and drinking
Children and adolescents who abuse alcohol or are sexually active are more likely to take methamphetamines (MA), also known as 'meth' or 'speed'. Research published today in the open access journal
BMC Pediatrics reveals the risk factors associated with MA use, in both low-risk children (those who don't take drugs) and high-risk children (those who have taken other drugs or who have ever attended juvenile detention centres).
Methamphetamine Enters Brain Quickly and Lingers
(PhysOrg.com) -- Using positron emission tomography (PET) to track tracer doses of methamphetamine in humans’ brains, scientists at the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory find that the addictive and long-lasting effects of this increasingly prevalent drug can be explained in part by its pharmacokinetics — the rate at which it enters and clears the brain, and its distribution. This study in 19 healthy, non-drug-abusing volunteers includes a comparison with cocaine and also looked for differences by race. It will appear in the November 1, 2008, issue of
Neuroimage.
Addiction treatment proves successful in animal weight loss study
Vigabatrin, a medication proposed as a potential treatment for drug addiction by scientists at the U.S. Department of Energy's Brookhaven National Laboratory, also leads to rapid weight loss and reduced food intake according to a new animal study from the same research group. The study will be published online August 20, 2008, by the journal
Synapse. Vigabatrin is currently undergoing U.S. Food and Drug Administration (FDA)-approved Phase II clinical trials against cocaine and methamphetamine addiction across the U.S.